Who to call at Cognito Therapeutics, and when
Fundz watches for the moments Cognito Therapeutics starts buying, and tells you who to reach.
- An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cognito Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cognito Therapeutics. With Fundz connected, it knows.
Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research.
Contract Type
partnership
CambridgeManufacturingBiotechnologyHealthcareHealth CareMedicalTherapeuticsDescription
The Rhode Island Life Science Hub has partnered with Cognito Therapeutics to inaugurate the Rhode Island Brain Health Collaboratory. This initiative aims to enhance collaboration between healthcare and research sectors in Rhode Island, focusing on Alzheimer's research and treatment.
Quick answer
Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026). Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- What agreement did Cognito Therapeutics announce on October 27, 2026?
- The Rhode Island Life Science Hub has partnered with Cognito Therapeutics to inaugurate the Rhode Island Brain Health Collaboratory. This initiative aims to enhance collaboration between healthcare and research sectors in Rhode Island, focusing on Alzheimer's research and treatment.
- What does Cognito Therapeutics do?
- Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance.
- Where is Cognito Therapeutics based?
- Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies announced agreements around the same time?
- Alexion (October 29, 2026), BioMarin Pharmaceutical (October 29, 2026), Georgiamune (October 25, 2026) and YD Bio Limited (October 20, 2026) also announced agreements within 45 days of Cognito Therapeutics.
Source: Fundz verified event record.
Other recent agreements in Healthcare and Medical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- BioMarin Enters Exclusive License Agreement With GC Biopharma and Hanmi Pharm for HM15421/GC1134A to Treat Fabry Disease. (October 29, 2026)
- Menarini and Georgiamune Enter $1.1 Billion License Agreement for Cancer Immunotherapy GIM-621. (October 25, 2026)
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- Boston Scientific and Heartflow Form Strategic Partnership to Enhance PCI Planning. (October 28, 2026)
- NVision Partners with HyperLight to Advance Photonic Quantum Chip Development. (October 28, 2026)
Related People
Agreement Insights
What this usually meansCognito Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.